Wagner W, Prott F J, Rübe C, Willich N
Paracelsus-Strahlenklinik, Osnabrück.
Strahlenther Onkol. 1996 Nov;172(11):604-9.
We have evaluated the records of patients who developed epidural metastases with spinal cord compression and underwent X-ray therapy in combination with dexamethasone. The results, prognostic factors and live-tables will be demonstrated.
Between 1984 and 1995 48 patients were treated at the Department of Radiooncology at the University of Münster because of epidural metastases. All but 3 cases were histologically proved. Three patients were irradiated without definitive histology because of clinical symptoms and CT or MR-imaging. Only patients with solid tumors were considered-patients with systemic diseases like leukemia or lymphoma were not analysed. In all of our cases irradiation was combined with systemic steroid application. Radiotherapy was performed with cobalt-60 or with an accelerator with total doses between 25 Gy and 40 Gy.
The combination of irradiation and steroids had resulted in pain relief in about 80% of all patients. The ambulatory status after paraparesis was restituted in 35%. Best prognosis had been seen in patients with the following criterions: primary tumor should be breast cancer, no evidence of other tumor manifestation, no signs of paraparesis or paraplegia before the beginning of irradiation or regaining the ambulatory status after therapy. Under these conditions we have calculated a median survival rate of 709 days for these patients with good prognosis. Patients with bronchogenic carcinoma had a very poor prognosis with a median survival rate of only 90 days.
Epidural metastases in cancer led often to a very fatal outcome. Irradiation is useful for pain relief and also for local tumor control. In some cases in patients with good prognostic factors long-time survival could be demonstrated. The results of irradiation are comparable with those after surgery.
我们评估了发生硬膜外转移并伴有脊髓压迫且接受了X线治疗联合地塞米松治疗的患者记录。将展示结果、预后因素和生存表。
1984年至1995年间,明斯特大学放射肿瘤学系因硬膜外转移对48例患者进行了治疗。除3例患者外,其余均经组织学证实。3例患者因临床症状及CT或磁共振成像检查而未获得确切组织学诊断就接受了放疗。仅纳入实体瘤患者——未分析白血病或淋巴瘤等全身性疾病患者。在我们所有的病例中,放疗均联合全身应用类固醇。使用钴-60或加速器进行放疗,总剂量在25 Gy至40 Gy之间。
放疗与类固醇联合应用使约80%的患者疼痛缓解。35%的患者轻瘫后恢复了行走能力。符合以下标准的患者预后最佳:原发肿瘤应为乳腺癌,无其他肿瘤表现证据,放疗开始前无轻瘫或截瘫迹象或治疗后恢复行走能力。在这些条件下,我们计算出这些预后良好的患者的中位生存期为709天。支气管肺癌患者预后很差,中位生存期仅为90天。
癌症患者的硬膜外转移常导致非常致命的结果。放疗有助于缓解疼痛并控制局部肿瘤。在一些预后因素良好的患者中可证明有长期生存。放疗结果与手术结果相当。